The vast majority of the oftalmologists think there is no cure for floaters (nor FOV or Laser) so, assuming this relation is right, we can assume the vast majority of laser and FOVdon't know about enzymatic vitrectomy... don't you think? ;-) or, thinking bad, any person than wait for a enzymatic vitrectomy tomorrow is a client lost for a mechannical vitrectomy today, sorry but money moves all.

As I told before, I don't know how much time is needed from one solution of this kind to be 100% operative, but I have found articles of enzymatic moving actively since 1999, so they are 9 years researching, they started with Vitrase that are not 100% effective, and has been found more solutions safer and more efective like microplasmin and plasmin with urokinase. The most promising seems microplasmin, but the most known and researched is plasmine, the main reason to don't become the "favorite" was that until just this year, the laboratory needed to make the microplasmin from your own blood has a huge cost, and just now they are getting to help "produce" the plasmin from your blood cheaper and in the same office to insert you. So, they are not getting the way to create the plasmin, also to make the process cheaper. 5 years? I think 5 years to be an standard... perhaps... but not to say "there are nothing in the horizon".

These are the Trials I have found about microplasmin in the link of trials I post at the beginning. You can check all the options there:

4 Recruiting A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction
Condition: Vitreomacular Traction
Intervention: Drug: Microplasmin


5 Recruiting A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin vs Sham Injection for Treatment of Patients With DME
Condition: Diabetic Macular Edema
Interventions: Drug: Microplasmin; Other: Sham injection

6 Active, not recruiting A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)
Condition: Vitreoretinal Disorders
Intervention: Drug: Microplasmin

8 Completed Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
Conditions: Vitreomacular Traction Maculopathy; Eye Diseases
Intervention: Drug: Microplasmin

There are studies in Phase II that started in 2005, so thery are moving... I have found trials in USA, Belgium, Germany, Netherlands, Spain and UK. I think the most the optalmologists know these options, the more trials they'll could start and the process to standarize these products will be quicker. I have found that some trials started in Dec 2006 and are still recruiting, so thinking there is no control of vitreous affected people, perhaps are having problems to get volunteers.

Loulou, I have read they are searching volunteers in Belgium for the Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction, and in the Studty for DME. Sorry, it's the more near to you I could found.

It's strange because when I visited the webpage of the vitreo and retina european oftalmologists, by far, France was the country most represented. Perhaps they are making their efforts in other compound or plasmine activator.

I hope this information get useful.